These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1471672)

  • 1. Transfer of Timentin (ticarcillin and clavulanic acid) across the in vitro perfused human placenta: comparison with other agents.
    Fortunato SJ; Bawdon RE; Swan KF; Bryant EC; Sobhi S
    Am J Obstet Gynecol; 1992 Dec; 167(6):1595-9. PubMed ID: 1471672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penetration of ticarcillin/clavulanate into cartilage.
    Meier H; Adam D; Heilmann HD
    J Antimicrob Chemother; 1989 Nov; 24 Suppl B():101-5. PubMed ID: 2606811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of ticarcillin/clavulanate in severely burned patients.
    Adam D; Zellner PR; Koeppe P; Wesch R
    J Antimicrob Chemother; 1989 Nov; 24 Suppl B():121-9. PubMed ID: 2606814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penetration of amoxycillin, ticarcillin and clavulanic acid into lymph after intravenous infusion in rabbits to simulate human serum pharmacokinetics.
    Woodnutt G; Berry V; Kernutt I; Mizen L
    J Antimicrob Chemother; 1990 Nov; 26(5):695-704. PubMed ID: 2079451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic-based ticarcillin/clavulanic acid dose recommendations for infants and children.
    Reed MD; Yamashita TS; Blumer JL
    J Clin Pharmacol; 1995 Jul; 35(7):658-65. PubMed ID: 7560245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and distribution of ticarcillin-clavulanic acid (Timentin) in experimental animals.
    Woodnutt G; Kernutt I; Mizen L
    Antimicrob Agents Chemother; 1987 Nov; 31(11):1826-30. PubMed ID: 3501702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational prescribing of extended-spectrum penicillin beta-lactamase inhibitor combinations: focus on ticarcillin/clavulanic acid.
    Reed MD
    Ann Pharmacother; 1998 Jan; 32(1):S17-21. PubMed ID: 9475835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels and pharmacokinetics of ticarcillin and clavulanic acid in dog following parenteral administration of Timentin.
    Garg RC; Keefe TJ; Vig MM
    J Vet Pharmacol Ther; 1987 Dec; 10(4):324-30. PubMed ID: 3501810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and bioavailability of ticarcillin and clavulanate in foals after intravenous and intramuscular administration.
    Wilson WD; Spensley MS; Baggot JD; Hietala SK; Pryor P
    J Vet Pharmacol Ther; 1991 Mar; 14(1):78-89. PubMed ID: 2038098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro models to predict the in vivo mechanism, rate, and extent of placental transfer of dideoxynucleoside drugs against human immunodeficiency virus.
    Tuntland T; Odinecs A; Pereira CM; Nosbisch C; Unadkat JD
    Am J Obstet Gynecol; 1999 Jan; 180(1 Pt 1):198-206. PubMed ID: 9914604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ticarcillin plus clavulanic acid: pharmacokinetic study in renal failure.
    Stathakis C; Bakounsli I; Iatrou C; Boletis J; Kosmidis J
    Chemioterapia; 1987 Jun; 6(2 Suppl):265-7. PubMed ID: 3509408
    [No Abstract]   [Full Text] [Related]  

  • 12. The pharmacokinetics of ticarcillin/clavulanate acid in neonates.
    Fricke G; Doerck M; Hafner D; Horton R; Kresken M
    J Antimicrob Chemother; 1989 Nov; 24 Suppl B():111-20. PubMed ID: 2606813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of ticarcillin/clavulanate on the intestinal microflora.
    Nord CE; Bergan T; Thorsteinsson SB
    J Antimicrob Chemother; 1989 Nov; 24 Suppl B():221-6. PubMed ID: 2606816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New antimicrobial agent series XXXVII: potassium clavulanate/Ticarcillin sodium].
    Fujimori I
    Jpn J Antibiot; 1991 Apr; 44(4):365-87. PubMed ID: 1880918
    [No Abstract]   [Full Text] [Related]  

  • 15. Clearance of ticarcillin-clavulanic acid by continuous venovenous hemofiltration in three critically ill children, two with and one without concomitant extracorporeal membrane oxygenation.
    Lindsay CA; Bawdon R; Quigley R
    Pharmacotherapy; 1996; 16(3):458-62. PubMed ID: 8726606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of in vitro kinetic models in the evaluation of beta-lactamase inhibitors.
    White A; Cooper C; Stokes D
    Chemioterapia; 1987 Jun; 6(2 Suppl):202-4. PubMed ID: 3509934
    [No Abstract]   [Full Text] [Related]  

  • 17. [Evaluation of the biliary excretion of a ticarcillin-clavulanic acid combination in man].
    Brogard JM; Blickle JF; Jehl F; Adloff M; Monteil H
    Pathol Biol (Paris); 1988 May; 36(5):500-6. PubMed ID: 3043347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ticarcillin-clavulanic acid pharmacokinetics in preterm neonates with presumed sepsis.
    Burstein AH; Wyble LE; Gal P; Diaz PR; Ransom JL; Carlos RQ; Forrest A
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2024-8. PubMed ID: 7811013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of ticarcillin and clavulanic acid given in combination to adult horses by intravenous and intramuscular routes.
    Sweeney RW; Beech J; Simmons RD; Soma LR
    J Vet Pharmacol Ther; 1988 Mar; 11(1):103-8. PubMed ID: 3379659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simulation of human serum pharmacokinetics of ticarcillin-clavulanic acid and ceftazidime in rabbits, and efficacy against experimental Klebsiella pneumoniae meningitis.
    Mizen L; Woodnutt G; Kernutt I; Catherall EJ
    Antimicrob Agents Chemother; 1989 May; 33(5):693-9. PubMed ID: 2665641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.